<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ru">
	<id>https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=ENTPD1</id>
	<title>ENTPD1 - История изменений</title>
	<link rel="self" type="application/atom+xml" href="https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=ENTPD1"/>
	<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=ENTPD1&amp;action=history"/>
	<updated>2026-06-15T01:27:56Z</updated>
	<subtitle>История изменений этой страницы в вики</subtitle>
	<generator>MediaWiki 1.43.6</generator>
	<entry>
		<id>https://transhumanist.ru/index.php?title=ENTPD1&amp;diff=6478&amp;oldid=prev</id>
		<title>OdysseusBot: Новая страница: «Ectonucleoside triphosphate diphosphohydrolase 1 (EC 3.6.1.5) (NTPDase 1) (Ecto-ATP diphosphohydrolase 1) (Ecto-ATPDase 1) (Ecto-ATPase 1) (Ecto-apyrase) (Lymphoi...»</title>
		<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=ENTPD1&amp;diff=6478&amp;oldid=prev"/>
		<updated>2021-05-12T15:32:41Z</updated>

		<summary type="html">&lt;p&gt;Новая страница: «Ectonucleoside triphosphate diphosphohydrolase 1 (EC 3.6.1.5) (NTPDase 1) (Ecto-ATP diphosphohydrolase 1) (Ecto-ATPDase 1) (Ecto-ATPase 1) (Ecto-apyrase) (Lymphoi...»&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Новая страница&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Ectonucleoside triphosphate diphosphohydrolase 1 (EC 3.6.1.5) (NTPDase 1) (Ecto-ATP diphosphohydrolase 1) (Ecto-ATPDase 1) (Ecto-ATPase 1) (Ecto-apyrase) (Lymphoid cell activation antigen) (CD39 antigen) [CD39]&lt;br /&gt;
&lt;br /&gt;
==Publications==&lt;br /&gt;
&lt;br /&gt;
{{medline-entry&lt;br /&gt;
|title=Ecto-NTPDase CD39 is a negative checkpoint that inhibits follicular helper cell generation.&lt;br /&gt;
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/32452837&lt;br /&gt;
|abstract=Vaccination is a mainstay in preventive medicine, reducing morbidity and mortality from infection, largely by generating pathogen-specific neutralizing antibodies. However, standard immunization strategies are insufficient with increasing age due to immunological impediments, including defects in T follicular helper (Tfh) cells. Here, we found that Tfh generation is inversely linked to the expression of the ecto-NTPDase CD39 that modifies purinergic signaling. The lineage-determining transcription factor [[BCL6]] inhibited CD39 expression, while increased Tfh frequencies were found in individuals with a germline polymorphism preventing transcription of [[ENTPD1]], encoding CD39. In in vitro human and in vivo mouse studies, Tfh generation and germinal center responses were enhanced by reducing CD39 expression through the inhibition of the cAMP/PKA/p-CREB pathway, or by blocking adenosine signaling downstream of CD39 using the selective adenosine A2a receptor antagonist istradefylline. Thus, purinergic signaling in differentiating T cells can be targeted to improve vaccine responses, in particular in older individuals who have increased CD39 expression.&lt;br /&gt;
&lt;br /&gt;
|keywords=* Adaptive immunity&lt;br /&gt;
* Aging&lt;br /&gt;
* Cellular senescence&lt;br /&gt;
* T cells&lt;br /&gt;
* Vaccines&lt;br /&gt;
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324201&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>OdysseusBot</name></author>
	</entry>
</feed>